What Is Section 280E and Why Is It Killing Cannabis Companies

If you spend any time reading about cannabis financials, the same three letters and three numbers keep appearing. 280E. They show up in earnings calls. In bankruptcy filings. In trade press obituaries for cannabis companies that didn't make it. And almost no one bothers to explain what 280E actually means, because the industry assumes you already know.

You don't have to. The basic idea is straightforward. The detailed implications are massive. And the future of American cannabis depends substantially on whether 280E gets fixed, eliminated, or worked around through litigation. Here's the explainer.

What Section 280E Actually Says

Section 280E is a provision of the Internal Revenue Code, the body of federal tax law that governs how American businesses calculate their taxes. The provision was enacted in 1982. It's brief, but its impact on cannabis is enormous.

The provision states, essentially, that no business "trafficking in controlled substances" prohibited by federal law (Schedule I or II of the Controlled Substances Act) can deduct ordinary business expenses for federal income tax purposes.

Read that again. Cannabis is a Schedule I controlled substance under federal law. State-licensed cannabis businesses are, in the federal government's view, "trafficking in controlled substances." Therefore, under Section 280E, those businesses cannot deduct rent. They cannot deduct payroll. They cannot deduct marketing. They cannot deduct utilities. They cannot deduct most of the expenses that any other business deducts as a matter of course.

The only thing they can deduct is cost of goods sold, which in cannabis means basically the cost of producing the actual product (cultivation costs for cultivators, wholesale purchase costs for retailers).

Why That Matters Mathematically

Most people don't think about how business taxation works because most businesses pay tax on a sensible base — profit. Profit is revenue minus expenses. If your business generates $1M in revenue and has $800,000 in legitimate business expenses, your taxable profit is $200,000, and you pay tax on that $200,000 at whatever applicable rate.

Section 280E breaks that math for cannabis.

A cannabis dispensary with $1M in revenue might have $400,000 in cost of goods sold (the wholesale cost of cannabis purchased from cultivators) and $400,000 in operating expenses (rent, payroll, utilities, etc.). In a normal business, taxable profit would be $200,000.

Under Section 280E, that dispensary's federally taxable income is calculated as $1M revenue minus $400,000 cost of goods sold equals $600,000 — even though the dispensary's actual economic profit is $200,000. The dispensary pays federal income tax on $600,000 of "profit" that mostly doesn't exist.

If the federal corporate tax rate is 21% and the dispensary's effective rate including state taxes is, say, 25%, the federal tax on the $600,000 is $150,000. That's 75% of the actual $200,000 economic profit, before the dispensary pays state income tax on top of that.

In practice, effective federal tax rates for cannabis businesses subject to 280E often run 60–80% of actual economic profit. Some operators report effective rates above 100% — meaning they pay more in federal taxes than they actually earn — which means the business operates at a federal-tax-induced loss even when it generates positive operating cash flow.

Why 280E Exists

The history is short and instructive. In the late 1970s, a convicted cocaine trafficker named Jeffrey Edmondson tried to deduct ordinary business expenses on the cocaine business he had been convicted of running. Astonishingly, the Tax Court agreed that Edmondson was entitled to the deductions — the tax code as it existed didn't distinguish between legal and illegal businesses for purposes of expense deductibility.

Congress was not pleased. Section 280E was passed in 1982 specifically to prevent illegal-drug traffickers from claiming business expense deductions. The legislative intent was to ensure that drug dealers couldn't reduce their tax bills by claiming the operational costs of their drug dealing.

When state-legal cannabis emerged decades later, Section 280E applied to it by virtue of cannabis remaining a Schedule I controlled substance under federal law. The drafters of 280E had not contemplated state-legal cannabis. The application to state-legal cannabis was an unintended consequence that nonetheless followed mechanically from the statutory language.

What Cost of Goods Sold Means in Cannabis

The one deduction Section 280E permits is cost of goods sold. The IRS has issued some guidance on how cannabis operators can calculate cost of goods sold, and tax planning around that calculation is one of the major industries supporting cannabis businesses.

For cannabis cultivators, cost of goods sold can include cultivation labor, growing supplies, indirect production costs, and similar items that a court might consider direct costs of producing the cannabis. For cannabis retailers, cost of goods sold is typically the wholesale purchase price of cannabis plus narrowly defined inventory-related expenses. The IRS has interpreted these categories restrictively, with significant operator-side litigation over what specifically qualifies.

Sophisticated cannabis tax planners spend substantial time and effort restructuring operations to maximize the cost-of-goods-sold deduction. Common strategies include separating cultivation, processing, and retail operations into distinct legal entities so that more costs can be characterized as cost-of-goods-sold by the operating entity rather than as non-deductible operating expenses; carefully classifying personnel to maximize the cost-of-goods-sold characterization of payroll; and structuring inventory accounting to capture more indirect costs as cost-of-goods-sold.

These strategies provide marginal relief but cannot eliminate the fundamental 280E burden. The federal tax rate on cannabis remains punitive even with optimal planning.

The Industry Strategies for Coping

Cannabis operators have responded to 280E with several strategies, ranging from compliance to aggressive non-compliance.

Comply and absorb. Many smaller operators simply pay the punitive 280E tax bill and try to operate around it. This produces the chronic margin compression that has driven small operator failure rates.

Comply and reorganize. Sophisticated operators restructure operations to maximize cost-of-goods-sold characterization, separate cannabis and non-cannabis activities, and otherwise minimize 280E exposure within the law. This requires substantial tax counsel investment that smaller operators cannot afford.

Withhold pending litigation. The largest MSOs have, increasingly, simply stopped paying federal taxes pending the resolution of legal challenges to 280E application. This is the strategy at the heart of the $1.6 billion in collective MSO unpaid tax balances. It is high-risk but defers the problem and provides a real chance of retroactive recovery if the litigation succeeds.

Sue the federal government. A coalition of MSOs, led by Ascend Wellness and Curaleaf, has been pursuing federal court litigation challenging both Section 280E and the underlying CSA application to state-legal cannabis. The litigation argues that 280E violates the Constitution as applied to state-legal businesses and that the federal government's authority over intrastate cannabis commerce is constitutionally limited. Outcomes pending.

Wait for rescheduling. A move to Schedule III would automatically eliminate 280E exposure prospectively, since 280E only applies to Schedule I and II substances. The DEA's rescheduling process has been in motion for years.

Wait for Congressional action. Various proposals to amend Section 280E to exclude state-legal cannabis have been introduced in Congress. None has passed. Lobbying efforts continue.

What This Means for the Industry

Section 280E has shaped American cannabis in ways that are not always obvious.

It has selected for capital-intensive operators who can absorb the punitive tax burden. The MSOs that dominate the industry are not necessarily better operators than the small businesses they have outcompeted; they are simply better at deploying capital around 280E.

It has created the conditions for the MSO debt crisis. The 280E burden combined with limited capital access has forced cannabis operators into expensive debt structures that are now coming due across the industry.

It has discouraged equity-owned operations. Capital-constrained equity applicants who cannot absorb 280E tax burdens face a higher rate of failure than well-capitalized peers, contributing to the equity ownership disparities that have undermined social equity programs.

It has driven illegal-market persistence. The cost differential between legal cannabis (subject to 280E plus other costs) and illegal cannabis (subject to neither) is substantial. The persistence of illegal cannabis markets is partly a 280E story.

It has structured the federal cannabis policy conversation. The dominant federal cannabis lobbying priorities have been driven by industry interest in 280E elimination. Other potential reform priorities have been deprioritized accordingly.

What This Means for Consumers

You pay 280E. The dispensary doesn't really. The MSO doesn't really. The federal tax burden is, like most taxes, ultimately passed through to the buyer. When you pay $55 for an eighth that costs $25 to produce and $5 to distribute, a meaningful portion of the markup is the dispensary's effort to cover its 280E exposure.

Consumers in states with regulated cannabis markets are, structurally, paying for federal cannabis prohibition through the prices they pay at dispensaries. The federal government does not directly tax your cannabis purchase, but it imposes costs on the businesses that sell it that those businesses pass through to you.

If 280E is eventually eliminated or worked around through rescheduling, prices should decline at retail — though the magnitude of price relief depends on how much of the savings operators retain as restored margin versus pass through to consumers.

What Reform Looks Like

Several specific reform paths could address the 280E problem.

Federal rescheduling to Schedule III. Would eliminate 280E exposure prospectively. Pending DEA finalization, with timing uncertain.

Congressional amendment to Section 280E. Would clarify that state-legal cannabis is exempt from 280E. Has been introduced repeatedly without passage.

Successful federal litigation. The MSO-led litigation challenging 280E could produce judicial relief if successful. The legal arguments are complex and the outcomes uncertain.

State-level workarounds. Some states have considered tax credits or other mechanisms to offset the 280E burden at the state level. Implementation has been limited.

Comprehensive federal cannabis legalization. Would eliminate the underlying federal illegality that triggers 280E. The most direct fix and the most politically difficult.

The Bottom Line

Section 280E is a 1982 anti-drug-trafficking provision that has, by virtue of cannabis remaining a Schedule I controlled substance, become the single largest financial burden on the state-legal cannabis industry. It distorts industry economics, advantages capital-rich operators, disadvantages equity applicants and small operators, and substantially explains why the cannabis industry looks the way it looks.

It is also, almost uniquely among major industry burdens, fixable through specific federal action. Rescheduling fixes it. Congressional amendment fixes it. Successful litigation fixes it. The fix is not technically difficult. It is politically and bureaucratically difficult, which is to say it is difficult in the ways most consequential federal reforms are difficult.

Until the fix arrives, the cannabis industry operates under a tax structure that no other industry experiences and that, by any sensible economic analysis, no industry should experience. The cost is paid by operators, workers, and consumers. The benefit accrues to the federal Treasury at a level that does not justify the distortion it produces.

Section 280E is a bug, not a feature. It needs to be fixed. The cannabis industry has been waiting for that fix for over a decade. The wait is the story.

---

Internal links:

• The $1.6 Billion the MSOs Owe the IRS →
• The $6 Billion Debt Wall →
• Why Are So Many Cannabis Dispensaries Closing in 2026 →